Henry Schein (NASDAQ:HSIC) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.38-3.50 for the period, compared to the Thomson Reuters consensus estimate of $3.42. Henry Schein also updated its FY 2019 guidance to $3.38-3.50 EPS.
Several research firms recently commented on HSIC. Wolfe Research began coverage on shares of Henry Schein in a report on Thursday. They issued an underperform rating on the stock. Svb Leerink reaffirmed a market perform rating and issued a $70.00 price objective (down previously from $75.00) on shares of Henry Schein in a research report on Wednesday, May 15th. Leerink Swann downgraded shares of Henry Schein from an outperform rating to a market perform rating and lowered their price objective for the company from $75.00 to $70.00 in a research report on Wednesday, May 15th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Henry Schein from a buy rating to a hold rating in a research report on Tuesday, May 14th. Finally, Barrington Research increased their price objective on shares of Henry Schein from $72.00 to $75.00 and gave the company an outperform rating in a research report on Wednesday, May 8th. Seven research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of Hold and an average target price of $74.27.
HSIC stock opened at $65.13 on Friday. Henry Schein has a twelve month low of $56.58 and a twelve month high of $91.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.65 and a quick ratio of 0.93. The company has a market cap of $9.71 billion, a PE ratio of 15.77, a P/E/G ratio of 2.32 and a beta of 0.89.
In other Henry Schein news, Director Philip A. Laskawy sold 1,084 shares of Henry Schein stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $59.86, for a total value of $64,888.24. Following the completion of the transaction, the director now owns 32,899 shares of the company’s stock, valued at $1,969,334.14. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.06% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: Coverage Ratio
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.